Hong Kong stocks Yingtai Medical "return to A" counseling period involved in Hangzhou "quasi-unicorn" equity dispute, Deno electrophysiology shareholder meeting two proposals questioned by four major investors

Three months ago, the "Denor Series" company - the "quasi-unicorn" Hangzhou Denor Electrophysiology Medical Technology Co., Ltd., was exposed by its shareholders to have a shareholder dispute over "anti-dilution rights and priority liquidation rights". Recently, there have been new developments in this acquisition case. I learned from the "Medicine Queen" Zhang Mingfang that Denor Electrophysiology will hold an extraordinary general meeting of shareholders on July 29 to consider the capital increase proposal provided by Shanghai Chenyao Fund and Eying Medical, as well as the amendment of the company's articles of association. Zhang Mingfang raised four questions about the contents of these two proposals: First, this capital increase is a "preparatory action" made by the major shareholder of the company to satisfy his own interests; Second, the capital increase and expansion of shares at a valuation of 500 million yuan has triggered the "anti-dilution rights" of minority shareholders of the investment party; Third, the company has refused to provide important information such as financial statements and audit reports to shareholders including Xinyuan Fukang; Fourth, Eying Medical has announced multiple times the acquisition of medical assets of the Denor series, mostly through low-priced acquisitions to achieve control rights and realize the exit of the actual controller's equity. In response to this, lawyer Wang Zhibin from Shanghai Minglun Law Firm told reporters that the Company Law clearly stipulates that shareholders have the right to access and copy financial accounting reports, and investment agreements or shareholder agreements usually have specific provisions on this. In the context of the company's planned capital increase and expansion of shares, financial information is an important basis for shareholders to exercise their voting rights, and the company should reasonably ensure that shareholders have the right to access relevant documents.